TickerFacts.

BridgeBio Pharma, Inc. (BBIO): Share Repurchases

Annual figures by period end, from SEC filings.

$48.28M
Year ended 2025-12-31
$210.00M
Trailing 12 months to 2026-06-30
-8.4%
5-year compound annual growth
$200.00M2020-12-31: $75.00M2021-12-31: $200.00M2022-12-31: $02023-12-31: $02024-12-31: $02025-12-31: $48.28M$48.28M
2020-12-31 Share Repurchases (USD) 2025-12-31
Period endedShare RepurchasesChange YoYSource filing
2025-12-31$48.28Mn/a2026-02-24, From 2025-01-01
2024-12-31$0n/a2026-02-24, From 2024-01-01
2023-12-31$0n/a2026-02-24, From 2023-01-01
2022-12-31$0-100.0%2024-02-22, From 2022-01-01
2021-12-31$200.00M+166.7%2024-02-22, From 2021-01-01
2020-12-31$75.00Mn/a2023-02-23, From 2020-01-01

Share Repurchases at similar companies

Companies with the same SEC industry code (Pharmaceutical Preparations), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShare RepurchasesChange YoY
BridgeBio Pharma, Inc. (BBIO)2025-12-31$48.28Mn/a
Nature's Sunshine Products Inc (NATR)2025-12-31$16.31M+84.1%
HUTCHMED (China) Ltd (HCM)2024-12-31$36.06M+297.6%
Organogenesis Holdings Inc. (ORGO)2024-12-31$25.48Mn/a
Opko Health, Inc. (OPK)2025-12-31$47.04M-47.9%
Innoviva, Inc. (INVA)2025-12-31$4.53M-69.3%
Amphastar Pharmaceuticals, Inc. (AMPH)2025-12-31$75.59M-11.6%
Pacira BioSciences, Inc. (PCRX)2025-12-31$148.33M+493.3%
Emergent BioSolutions Inc. (EBS)2025-12-31$24.90Mn/a

Compare BBIO, NATR, HCM, ORGO side by side · Screen every company in Pharmaceutical Preparations ↗